Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “nateglinide”

5 pharma patents match "nateglinide" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 5
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 5 pharmaceutical patents matching "nateglinide" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

5 results for “nateglinide” · 30,257 patents in full index Clear search

  1. US 7534913

    Crystalline form of nateglinide

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 19, 2009 · Expires May 14, 2029

    granted

  2. US 7420084

    Polymorphic forms of nateglinide

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted

  3. US 7358390

    Polymorphic forms of nateglinide

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 15, 2008 · Expires Apr 10, 2028

    granted

  4. US 7148376

    Polymorphic forms of nateglinide

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 12, 2006 · Expires Dec 7, 2026

    granted

  5. US 6861553

    Process for preparing nateglinide and intermediates thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 1, 2005 · Expires Feb 24, 2025

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.